| Breakdown | TTM | Jan 2025 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.13M | 91.34M | 81.66M | 72.47M | 67.58M | 53.18M |
| Gross Profit | 36.63M | 33.05M | 28.50M | 23.69M | 20.45M | 14.69M |
| EBITDA | 4.42M | 6.88M | 5.86M | 6.42M | 4.18M | 732.00K |
| Net Income | 1.85M | 1.43M | 1.22M | 3.08M | 2.42M | -1.31M |
Balance Sheet | ||||||
| Total Assets | 70.76M | 64.34M | 59.92M | 58.08M | 50.62M | 42.70M |
| Cash, Cash Equivalents and Short-Term Investments | 12.46M | 12.06M | 15.77M | 16.60M | 15.00M | 5.98M |
| Total Debt | 12.53M | 12.86M | 11.56M | 11.05M | 10.19M | 10.52M |
| Total Liabilities | 29.99M | 24.92M | 21.39M | 21.66M | 17.48M | 17.21M |
| Stockholders Equity | 40.77M | 39.42M | 38.52M | 36.41M | 33.15M | 25.49M |
Cash Flow | ||||||
| Free Cash Flow | -58.00K | -275.00K | 3.55M | 3.23M | 5.22M | -3.93M |
| Operating Cash Flow | 3.96M | 3.88M | 6.48M | 4.76M | 6.94M | -953.00K |
| Investing Cash Flow | -4.42M | -4.88M | -2.93M | -1.52M | -1.77M | -5.45M |
| Financing Cash Flow | -3.99M | -2.61M | -1.83M | -1.63M | 3.85M | -1.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £817.22M | 8.94 | 7.83% | 6.51% | -1.35% | -12.67% | |
70 Outperform | £49.30M | 7.74 | 10.10% | ― | 15.50% | 314.96% | |
67 Neutral | £286.73M | 5.52 | -6.79% | 6.30% | 3.31% | -340.97% | |
65 Neutral | £1.63B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
64 Neutral | £35.68M | 4.08 | 4.60% | ― | 17.79% | 18.96% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £26.88M | -1.20 | 63.25% | ― | -1.96% | 28.69% |